GSX1

GSX1 is classified as an activator and developmental protein. It plays a significant role in various biological processes, including transcription and transcription regulation. The protein features a DNA-binding domain and is predominantly localized in the cell nucleus, where it influences the expression of target genes.^[11]

One of the key functions of GSX1 is its involvement in the expression of the growth hormone-releasing hormone (GHRH) gene. Research indicates that GSX1, known as Gsh-1 in mice, is essential for GHRH gene expression.

A study demonstrated that the absence of Gsh-1 in knockout mice resulted in a dwarf phenotype and a complete loss of GHRH expression. This study elucidated that GSX1 binds to multiple regulatory sites in the GHRH promoter, enhancing its transcriptional activity, especially in the presence of CREB-binding protein, indicating a cooperative regulatory mechanism within the hypothalamus.^[6]

GSX1 plays a critical role in the development of specific neurons involved in sensory processing and cognitive regulation. Research has shown that GSX1-expressing neurons are essential for prepulse inhibition, a mechanism that helps the brain filter out irrelevant information and prevent cognitive overload. In studies using larval zebrafish and GSX1 knockout mice, the absence or silencing of these neurons resulted in significant impairments in prepulse inhibition, because they are involved in initiating startle responses.^[7]

GSX1 has been implicated in tissue regeneration strategies, particularly in the context of spinal cord injury (SCI).

Promoting resident cells, especially neural stem and progenitor cells (NSPCs), is a potential approach for treating SCI. However, adult NSPCs primarily differentiate into glial cells (a type of brain cell that's not a neuron and helps support neural structure), contributing to glial scar formation at injury sites, which isn't useful.^[12]

GSX1, in its developmental role, regulates the generation of excitatory and inhibitory interneurons during spinal cord embryonic development.

Recent studies show that lentivirus-mediated expression of GSX1 increases the number of NSPCs in a mouse model of SCI during shortly after injury. This expression subsequently boosts the generation of glutamatergic and cholinergic interneurons while decreasing the production interneurons that produce GABA in the long term. ^[8]

This ultimately means that GSX1 expression reduces reactive astrogliosis and glial scar formation, enhances serotonin neuronal activity, and improves locomotor function in injured mice, leading to better long-term outcomes.^[8]